The White House is moving forward with a plan to dramatically slash drug costs after talks broke down with the pharmaceutical industry's major lobby, the POLITICO website reports today (September 14, 2020).
President Donald Trump tweeted yesterday that he signed a new executive order for a "most favored nations" plan.
The plan would tie payments for certain Medicare drugs to the significantly lower costs the treatments sell for abroad.
Currently, prescription drugs in many foreign countries are less than half the cost as in the U.S., which has resulted in more than a million Americans purchasing their drugs from Canada and other foreign countries each year.
No comments:
Post a Comment